Remember Me Don't have an account? Register Forgotten password? Reset it
The website of the Clinical Services Journal

Disinfectant wipe meets new standard

PAL INTERNATIONALhas combined the launch of its latest product with a campaign to raise awareness of the first real-world European test for chemical disinfectant wipes.

These wipes are widely and increasingly used in healthcare environments, but until the introduction of EN 16615:2015 there was no dedicated efficacy testing for such wipes. 

Responding to healthcare market demand for a robust single product, the company has applied its technical expertise, as well as an understanding of the strict regulations surrounding the use of disinfectant chemicals, to introduce the Medipal 3 in 1 disinfectant wipe which complies with the new standard. Also known as the 4-field test, the application of EN 16615:2015 requires products to achieve a 99.999% reduction for bacteria and a 99.99% reduction for yeast. However, the standard, developed by German experts and applicable EU-wide, has so far gained little attention or adoption in the UK.

Speaking after the launch of the new product, Alex Brucciani, managing director for Pal International commented: “I am struck by the confusion in the market regarding the correct regulatory standard to follow in any purchasing decisions. While there is a 3-Stage Test for disinfectant wipes, it has not been adopted by the European Committee for Standardisation (CEN) to become an EN standard. EN16615 has however been approved, making it the reference standard for testing disinfectant wipes.”

 

 

More about Pal International

 

Other news

Upcoming Events

Crossing Continents, Sharing Knowledge

Queen Elizabeth Hospital Birmingham
1st April 2017

The British Society of Audiology Annual Conference

Majestic Hotel, Harrogate
29th – 30th June 2017

Latest Issue

Clinical Services Journal

Clinical Services Journal

Mar 2017

The evolution of patient warming

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.